Horizon Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Horizon Wealth Management's ABBV Position: Q2 2026 in Review
Horizon Wealth Management increased its AbbVie (ABBV) stake by 11% in Q2 2026, buying an estimated $90.1K and bringing the position to 4,157 shares worth $1.05M. The position accounts for 0.13% of the portfolio, ranked #63.
Horizon Wealth Management first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Horizon Wealth Management held 4,157 shares of AbbVie worth $1.05M as of Q2 2026.
- Horizon Wealth Management bought 419 AbbVie shares in Q2 2026, an estimated $90.1K.
- AbbVie made up 0.13% of Horizon Wealth Management's portfolio in Q2 2026, its #63 holding.
- Horizon Wealth Management first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
- 4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Horizon Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.